Study of FG-4592 in Subjects With Chronic Kidney Disease in China

Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

NCT01630889 ·Status: COMPLETED ·Phase: PHASE2

Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

NCT04925011 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease

NCT03976115 ·Status: COMPLETED ·Phase: PHASE1

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

NCT01414075 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease

NCT04059913 ·Status: COMPLETED ·Phase: PHASE4

Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis

NCT00761657 ·Status: COMPLETED ·Phase: PHASE2

Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis

NCT01736397 ·Status: COMPLETED ·Phase: PHASE2

Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D

NCT02492620 ·Status: COMPLETED ·Phase: PHASE3

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

NCT04154670 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

NCT02174627 ·Status: COMPLETED ·Phase: PHASE3

Study of Aldafermin (NGM282) in Participants With Impaired Renal Function

NCT04179630 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment

NCT05947097 ·Status: UNKNOWN ·Phase: PHASE1

A Crossover Safety Study of Ferumoxytol Versus Placebo

NCT00255450 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

NCT04950114 ·Status: TERMINATED ·Phase: PHASE2

Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease

NCT06248567 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients

NCT00548691 ·Status: COMPLETED ·Phase: PHASE3

A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation

NCT05379829 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

NCT05089279 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy

NCT05136456 ·Status: UNKNOWN ·Phase: PHASE2

Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Renal Function

NCT06106126 ·Status: UNKNOWN ·Phase: NA

Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)

NCT00782561 ·Status: TERMINATED ·Phase: PHASE1

Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis

NCT00956059 ·Status: UNKNOWN ·Phase: NA

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

NCT04456803 ·Status: COMPLETED ·Phase: PHASE3

SAL-0951 Tablets in the Treatment of Renal Anemia in Non-dialysis Chronic Kidney Disease

NCT06016036 ·Status: COMPLETED ·Phase: PHASE3

Obinutuzumab in Treatment of Fibrillary Glomerulonephritis

NCT06295770 ·Status: RECRUITING ·Phase: PHASE2